Ondansetron Accordpharma

Ondondansetron, the active ingredient in Ondansetron Accordpharma, is a 5-HT3 receptor antagonist presented as a 4 mg tablet for oral use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery in adult patients. GNH USA supplies Ondansetron Accordpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacy stores worldwide.

GNH USA supplies Ondansetron Accordpharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Ondansetron is a selective 5‑HT3 receptor antagonist that blocks the emetic pathway in the central nervous system.

- Chemotherapy‑induced nausea and vomiting: Provides preventive and protective effects against vomiting and nause during chemotherapy. - Radiotherapy t     .... - ... ");